Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Quality of life in patients with acute myeloid leukemia

Schumacher, A.

Medizinische Klinik 89(8): 410-415

1994

ISSN/ISBN: 0723-5003
PMID: 7968873
Document Number: 7457
In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest. The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy. Preliminary results show the psychooncological relevance of the study for the clinician.

Document emailed within 1 workday
Secure & encrypted payments

Quality of life in patients with acute myeloid leukemia

Schumacher, A.; Kessler, T.; Riedel, A.; Büchner, T.; van de Loo, J. 1996: Quality of life and coping with illness in patients with acute myeloid leukemia Psychotherapie Psychosomatik Medizinische Psychologie 46(11): 385-390
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Greiner, J.; Döhner, H.; Schmitt, M. 2006: Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens Haematologica 91(12): 1653-1661
Kuse, R. 2000: The therapy of acute myeloid leukemia in patients of advanced age Deutsche Medizinische Wochenschrift 125(9): 272
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Bakhudze, E.V.; Evstigneeva, L.A.; Leenman, E.E.; Klimashevskiĭ, V.F.; Morozova, E.V.; Shashkova, N.G. 2006: Myeloid sarcoma of the uterine cervix as presentation of acute myeloid leukemia Voprosy Onkologii 52(1): 102-104
Promsuwicha, O.; Auewarakul, C.U. 2009: Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations Asian Pacific Journal of Allergy and Immunology 27(4): 209-216
Martín-González, R.; Ortiz de Salazar, A.; Peris-Martí, A.; Valiente-Ibiza, E.; Sala-Corbí, A. 2000: Life events, quality of life and social support prior to acute cerebral vascular disease, as predictive factors of the quality of life and functional state following stroke Revista de Neurologia 30(8): 707-711
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356
Petit, P.; Van Den Berghe, H. 1979: The 5q- and additional chromosome anomalies in two patients with acute myeloid leukemia Annales de Genetique 22(2): 103-105
Aurer, I.; Kolevska, T.; Labar, B.; Kracun, I.; Nemet, D.; Marusić, M.; Bogdanić, V. 1988: Bone marrow cultures from patients with acute myeloid leukemia Lijecnicki Vjesnik 110(12): 405-409
DiNardo, C. 2018: Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation Clinical Advances in Hematology and Oncology: H&o 16(4): 247-249
Harrison, C.J. 2005: Detection of genomic aberrations in older patients with acute myeloid leukemia Haematologica 90(2): 147
Calabrese, G.; Fantasia, D.; Spadano, A.; Morizio, E.; Di Bartolomeo, P.; Palka, G. 2000: Karyotype refinement in five patients with acute myeloid leukemia using spectral karyotyping Haematologica 85(11): 1219-1221
Trnková, Z.; Bedrlíková, R.; Marková, J.; Michalová, K.; Stöckbauer, P.; Schwarz, J. 2007: Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia Neoplasma 54(5): 383-390
Niparuck, P.; Chuncharunee, S.; Ungkanont, A.; Udomtrupayakul, U.; Aungchaisuksiri, P.; Rerkamnuatchoke, B.; Jootar, S.; Atichartakarn, V. 2009: Long-term outcomes of de novo acute myeloid leukemia in Thai patients Journal of the Medical Association of Thailand 92(9): 1143-1149